Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 2Thoracic 1Sarcoma 1Plasma cell 1Myeloid 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Classical hematology 1CNS 1Breast 1

Conditions

Lymphoma, Large B-Cell, Diffuse 6Leukemia, Lymphocytic, Chronic, B-Cell 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Mantle-Cell 4Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Lymphoma 3Neoplasms 2Multiple Myeloma 2Burkitt Lymphoma 2Breast Neoplasms 2Vulvar Neoplasms 1Venous Thromboembolism 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Skin Neoplasms 1Sezary Syndrome 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Myelofibrosis 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Pathologic Complete Response 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Mycosis Fungoides 1

Interventions

Cyclophosphamide 447Rituximab 406Etoposide 225Vincristine 217Doxorubicin 204Filgrastim 201Prednisone 178Cytarabine 160Radiotherapy 152fludarabine phosphate 148Methotrexate 137Peripheral Blood Stem Cell Transplantation 130Melphalan 128fludarabine 116Busulfan 101Dexamethasone 93Tacrolimus 76Carmustine 74Granulocyte Colony-Stimulating Factor 73Mycophenolic Acid 72Gemcitabine 66Bortezomib 65Antilymphocyte Serum 65Whole-Body Irradiation 63Bendamustine Hydrochloride 63Lenalidomide 62Cyclosporine 62Ifosfamide 58sargramostim 51Methylprednisolone 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Lymphoma × Observation × Lymphoid × Clear all
NCT05179824 2025-05-06

Tempus Priority Study: A Pan-tumor Observational Study

Tempus AI

Active not recruiting
1,000 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmSarcomaThoracic

Bile Duct Neoplasms, Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Skin Neoplasms, Stomach Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT00114738 2022-10-10

EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
53 enrolled 15 charts
Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

NCT01855698 2018-03-22

PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism

Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed
99 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Hematologic Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡